Bile duct stricture

Changed by Daniel J Bell, 13 May 2020

Updates to Article Attributes

Body was changed:

Bile duct strictures are problematic in terms of management and distinction between benign and malignant.

Pathology

Aetiology

There are numerous causes of biliary duct strictures, including 1,2 :

Although identification of malignant cells on washings obtained during ERCP can make the diagnosis, they are negative in 25-50% of cases 1. Careful imaging is therefore often required.

Carcinoembryonic antigen (CEA) and CA 19-9 are sometimes expressedsecreted by cholangiocarcinomacholangiocarcinomas

Radiographic features

The distinction between malignant and benign structures relies on two aspects:

  1. morphology of the stricture
  2. associated findings, pointing to a cause

As far as assessing the morphology of the stricture, modalities that image the lumen (ERCP, MRCP, CT IVCintravenous cholangiograms) are best, whereas to assess for associated features US or CT/MRI are better.

Stricture morphology

Benign features include 2:

  • smooth
  • tapered margins

Malignant features include:

  • irregular
  • shouldered margins
  • thickened (>1.5 mm) and enhancing (on arterial and or portal venous phase) duct walls 2

It is often difficult to distinguish between malignant and benign strictures, especially if short 2.

Associated findings

Associated findings are for example:

  • features of chronic pancreatitis
  • evidence of previous cholecystectomy
  • lymph node enlargement
  • infiltrating mass

Treatment and prognosis

Treatment and prognosis clearly depend on the underlying aetiology.

For benign stricture and number of options exist, including:

  • cholangioplasty: percutaneous or retrograde balloon dilation 3
  • stent placement: only considered in failed cholangioplasty and no other surgical options
  • surgery with resection of the stenotic segment and re-anastomosis or choledochoenterostomy (e.g. Roux-en-Y)
  • -</ul><p>Although identification of malignant cells on washings obtained during ERCP can make the diagnosis, they are negative in 25-50% of cases <sup>1</sup>. Careful imaging is therefore often required.</p><p><a href="/articles/carcinoembryonic-antigen">Carcinoembryonic antigen</a> (CEA) and <a href="/articles/ca-19-9">CA 19-9</a> are sometimes expressed by cholangiocarcinoma. </p><h4>Radiographic features</h4><p>The distinction between malignant and benign structures relies on two aspects:</p><ol>
  • +</ul><p>Although identification of malignant cells on washings obtained during <a title="ERCP" href="/articles/endoscopic-retrograde-cholangiopancreatography">ERCP</a> can make the diagnosis, they are negative in 25-50% of cases <sup>1</sup>. Careful imaging is therefore often required.</p><p><a title="Carcinoembryonic antigen (CEA)" href="/articles/cea">Carcinoembryonic antigen (CEA)</a> and <a href="/articles/ca-19-9">CA 19-9</a> are sometimes secreted by cholangiocarcinomas. </p><h4>Radiographic features</h4><p>The distinction between malignant and benign structures relies on two aspects:</p><ol>
  • -</ol><p>As far as assessing the morphology of the stricture, modalities that image the lumen (ERCP, MRCP, CT IVC) are best, whereas to assess for associated features US or CT/MRI are better.</p><h5>Stricture morphology</h5><p><strong>Benign features include</strong> <sup>2</sup>:</p><ul>
  • +</ol><p>As far as assessing the morphology of the stricture, modalities that image the lumen (ERCP, <a title="Magnetic resonance cholangiopancreatography (MRCP)" href="/articles/magnetic-resonance-cholangiopancreatography-mrcp-2">MRCP</a>, <a title="CT intravenous cholangiograms (CT IVC)" href="/articles/ct-cholangiography">CT intravenous cholangiograms</a>) are best, whereas to assess for associated features US or CT/MRI are better.</p><h5>Stricture morphology</h5><p><strong>Benign features include</strong> <sup>2</sup>:</p><ul>

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.